Luke V. Selby

Dr. Luke V. Selby


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 July 2015 in Journal of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
VSVivian E. Strong
Vivian E. Strong
AWAi-Wen Wu
Ai-Wen Wu
LSLuke V. Selby
Luke V. Selby
MGMithat Gonen
Mithat Gonen
MHMeier Hsu
Meier Hsu
MBMurray F. Brennan
Murray F. Brennan

29 January 2015 in Annals of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
KKKaitlyn J. Kelly
Kaitlyn J. Kelly
LSLuke V. Selby
Luke V. Selby
JCJoanne F. Chou
Joanne F. Chou
KDKaterina Dukleska
Katerina Dukleska
MCMarinela Capanu
Marinela Capanu
VSVivian E. Strong
Vivian E. Strong

16 October 2014 in Annals of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
VSVivian E. Strong
Vivian E. Strong
LSLuke V. Selby
Luke V. Selby
MSMindy Sovel
Mindy Sovel
JDJoseph J. Disa
Joseph J. Disa
WHWilliam Hoskins
William Hoskins
DJDavid P. Jaques
David P. Jaques

5 January 2016 in Annals of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
JDJeremy L. Davis
Jeremy L. Davis
LSLuke V. Selby
Luke V. Selby
JCJoanne F. Chou
Joanne F. Chou
MSMark Schattner
Mark Schattner
DIDavid H. Ilson
David H. Ilson
VSVivian E. Strong
Vivian E. Strong

1 May 2015 in Journal of the American College of Surgeons
Verified
Journal Article
Closed access
LSLuke V. Selby
Luke V. Selby
EVEmily A. Vertosick
Emily A. Vertosick
DSDaniel D. Sjoberg
Daniel D. Sjoberg
MSMark A. Schattner
Mark A. Schattner
YJYelena Y. Janjigian
Yelena Y. Janjigian
VSVivian E. Strong
Vivian E. Strong
Surgical quality improvement requires well-defined benchmarks and accurate reporting of postoperative adverse events, which have not been well defined for total gastrectomy. Detailed postoperative outcomes on 238 patients who underwent total gastrectomy with curative intent, from 2003 to 2012, were reviewed by a dedicated surgeon chart reviewer to establish 90-day patterns of adverse events. Of the 238 patients with stage I to III gastric adenocarcinoma who underwent curative-intent total gastrectomy, the median age was 66 years, and 68% were male. Median body mass index was 28 kg/m(2), and 68% of patients had at least 1 medical comorbidity. Forty-three percent of our patients received neoadjuvant chemotherapy, and 34% received postoperative adjuvant chemotherapy. Over the 90-day study period, 30-day mortality was 2.5% (6 of 238), and 90-day mortality was 2.9% (7 of 238). At least 1 postoperative adverse event was documented in 62% of patients, with 28% of patients experiencing a major adverse event requiring invasive intervention. The readmission rate was 20%. Anemia was the most common adverse event (20%), followed by wound complications (18%). The most common major adverse event was esophageal anastomotic leak, which required invasive intervention in 10% of patients. This analysis has defined comprehensive 90-day patterns in postoperative adverse events after total gastrectomy with curative intent in a Western population. This benchmark allows surgeons to measure, compare, and improve outcomes and informed consent for this surgical procedure.

14 November 2008 in Langmuir
Verified
Journal Article
Closed access
HHHuang-Chiao Huang
Huang-Chiao Huang
PKPiyush Koria
Piyush Koria
SPSarah M. Parker
Sarah M. Parker
LSLuke V. Selby
Luke V. Selby
ZMZaki Megeed
Zaki Megeed
KRKaushal Rege
Kaushal Rege